Literature DB >> 12562538

Small, dense low-density lipoprotein: risk or myth?

Ngoc-Anh Le1.   

Abstract

Based on the particle diameter of the major subpopulation of low-density lipoprotein (LDL) in plasma, an individual may be classified either as having phenotype A (desirable phenotype; large, buoyant LDL) or phenotype B (high risk; small, dense LDL). This article reviews the clinical significance of LDL particle diameter determination and proposes a strategy for incorporating this information in the new guidelines of the National Cholesterol Education Program's Adult Treatment Panel III.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562538     DOI: 10.1007/s11883-003-0064-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  44 in total

1.  A genetic determinant of the phenotypic variance of the molecular weight of low density lipoprotein.

Authors:  W R Fisher; M G Hammond; M C Mengel; G L Warmke
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project.

Authors:  B D Miller; E L Alderman; W L Haskell; J M Fair; R M Krauss
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

3.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.

Authors:  A Zambon; J E Hokanson; B G Brown; J D Brunzell
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

Review 4.  Phospholipase A(2) in vascular disease.

Authors:  E Hurt-Camejo; G Camejo; H Peilot; K Oörni; P Kovanen
Journal:  Circ Res       Date:  2001-08-17       Impact factor: 17.367

5.  Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women.

Authors:  M C Carr; A F Ayyobi; S J Murdoch; S S Deeb; J D Brunzell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

Review 6.  APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.

Authors:  N O Davidson; G S Shelness
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

7.  Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.

Authors:  N A Le; W Innis-Whitehouse; X Li; R Bakker-Arkema; D Black; W V Brown
Journal:  Metabolism       Date:  2000-02       Impact factor: 8.694

8.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

9.  Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.

Authors:  J Melish; N A Le; H Ginsberg; D Steinberg; W V Brown
Journal:  Am J Physiol       Date:  1980-11

10.  The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.

Authors:  W R Fisher; L A Zech; P Bardalaye; G Warmke; M Berman
Journal:  J Lipid Res       Date:  1980-08       Impact factor: 5.922

View more
  1 in total

1.  Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?

Authors:  Harold Bays; Scott Conard; Lawrence A Leiter; Steven Bird; Erin Jensen; Mary E Hanson; Arvind Shah; Andrew M Tershakovec
Journal:  Lipids Health Dis       Date:  2010-11-30       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.